Table 1

Disease modifying antirheumatic drug (DMARD) treatment within the previous 12 months in patients with rheumatoid arthritis by disease duration; comparison of new patients and patients treated by rheumatologists (1998; values are percentages)

  • The sums total more than 100% because some patients in both groups had received different individual drugs successively.

  • 1-150 Differences are significant on the 0.001 level.

  • 1-151 Without 189 cases who were referred by rheumatologists.

  • 1-152 Without 35 cases who were referred by rheumatologists.

  • 1-154 SSZ = sulfasalazine; MTX = methotrexate; AZA = azathioprine.